24 results on '"Ata, Baris"'
Search Results
2. Effect of the endometrial thickness on the live birth rate: insights from 959 single euploid frozen embryo transfers without a cutoff for thickness.
- Author
-
Ata, Baris, Liñán, Alberto, Kalafat, Erkan, Ruíz, Francisco, Melado, Laura, Bayram, Asina, Elkhatib, Ibrahim, Lawrenz, Barbara, and Fatemi, Human M.
- Subjects
- *
EMBRYO transfer , *BIRTH rate , *RECEIVER operating characteristic curves , *REPRODUCTIVE technology , *LOGISTIC regression analysis - Abstract
To investigate whether endometrial thickness (ET) independently affects the live birth rate (LBR) after embryo transfer. Retrospective study. Private assisted reproductive technology center. A total of 959 single euploid frozen embryo transfers. Vitrified euploid blastocyst transfer. Live birth rate per embryo transfer. The conditional density plots did not demonstrate either a linear relationship between the ET and LBR or a threshold below which the LBR decreased perceivably. Receiver operating characteristic curve analyses did not suggest a predictive value of the ET for the LBR. The area under the curve values were 0.55, 0.54, and 0.54 in the overall, programmed, and natural cycle transfers, respectively. Logistic regression analyses with age, embryo quality, day of trophectoderm biopsy, body mass index, and ET did not suggest an independent effect of the ET on the LBR. We did not identify a threshold of the ET that either precluded live birth or under which the LBR decreases perceivably. Common practice of cancelling embryo transfers when the ET is <7 mm may not be justified. Prospective studies, in which the management of the transfer cycle would not be altered by ET, would provide higher-quality evidence on the subject. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Why ovarian stimulation should be aimed to maximize oocyte yield.
- Author
-
Ata, Baris
- Subjects
- *
INDUCED ovulation , *OVARIAN hyperstimulation syndrome , *OVARIES , *OVUM , *MENSTRUAL cycle , *FROZEN human embryos - Abstract
The ultimate measure of success of assisted reproductive technology (ART) is the cumulative live birth rate (CLBR) per ovarian stimulation cycle, which increases with every oocyte collected. However, the adverse effects of ovarian stimulation on endometrial receptivity, as well as the risks of ovarian hyperstimulation syndrome (OHSS) and adverse obstetric and neonatal outcomes, are observed to increase with ovarian response to stimulation. To mitigate these risks, mild stimulation has been hailed as the safer patient-friendly approach with the additional benefit of cutting the cost of gonadotrophins. Yet accumulating data demonstrate the absence of an adverse effect of ovarian stimulation on oocytes as well as on obstetric and neonatal outcomes, and multiple preventive strategies have been introduced for OHSS. The widespread use of vitrification revolutionized ART by enabling the liberal use of cycle segmentation to minimize the risk of OHSS and avoid impaired endometrial receptivity due to ovarian stimulation. Vitrification also allowed every oocyte to contribute to the CLBR. Thus, it is questionable whether the cost savings from gonadotrophins during the index ovarian stimulation offset the cost saving by preventing repeat ovarian stimulation and repeat laboratory procedures per live birth. This paper aims to prove by contradiction that ovarian stimulation should be aimed to maximize oocyte yield. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Endometriosis, staging, infertility and assisted reproductive technology: time for a rethink.
- Author
-
Ata, Baris and Somigliana, Edgardo
- Subjects
- *
REPRODUCTIVE technology , *ENDOMETRIOSIS , *SEXUAL cycle , *INFERTILITY , *BIRTH rate , *SURGICAL excision - Abstract
How endometriosis causes infertility, with the exception of tubal dysfunction caused by adhesions, is unclear. The inflammatory milieu in the pelvis and impaired receptivity of the eutopic endometrium are considered to be possible factors. Anatomical staging systems fail to predict the fertility status of endometriosis patients. Data from assisted reproductive technology cycles consistently suggest that oocytes from patients with endometriosis have a normal potential to develop into euploid blastocysts. Moreover, oocyte or embryo recipients with endometriosis seem to have similar or slightly lower pregnancy and live birth rates compared with recipients without endometriosis, suggesting that eutopic endometrium is not or is only minimally affected, which may be caused by undiagnosed adenomyosis. In-vivo observations from women with endometriomas provide evidence against a detrimental effect of endometriomas on oocytes. Combined with the absence of an obvious improvement in fertility following the surgical destruction or excision of peritoneal endometriosis or from temporary medical suppression of the disease and the associated inflammation, the available evidence makes endometriosis-associated infertility questionable in the absence of tubal dysfunction caused by adhesions. It is likely that no anatomical staging will correlate with fertility beyond assessing tubal function. In patients with endometriosis assisted reproductive technology is as effective as for other indications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Response to: Cumulative live birth rate following progestin-primed ovarian stimulation: controversial results with own and donated oocytes.
- Author
-
Ata, Baris and Kalafat, Erkan
- Subjects
- *
INDUCED ovulation , *BIRTH rate , *OVUM , *BLASTOCYST - Published
- 2024
- Full Text
- View/download PDF
6. Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Uterine Myomas: A Systematic Review and Network Meta-analysis of Efficacy Parameters and Adverse Effects.
- Author
-
Telek, Savci Bekir, Gurbuz, Zeynep, Kalafat, Erkan, and Ata, Baris
- Abstract
Objective: The aim of this systematic review is to gather and synthesize evidence regarding the use of oral gonadotrophin-releasing hormone (GnRH) antagonist for the treatment of bleeding associated with uterine myomas.Data Sources: Web of Science, and MEDLINE databases were searched electronically on March 5, 2021, using combinations of the relevant Medical Subject Headings terms and keywords. The search was restricted to the English language and to human studies.Methods Of Study Selection: Only randomized controlled trials involving patients with heavy menstrual bleeding associated with uterine myomas treated with different doses of oral nonpeptide GnRH antagonists with or without add-back therapy were included. Studies comparing oral nonpeptide GnRH antagonists with treatments other than placebo were also excluded.Tabulation, Integration, and Results: A total of 5 randomized trials including 2463 women were included in the analyses. Included studies were found to be at low risk of bias. When treatments were compared against placebo, the top 3 treatments for bleeding suppression were elagolix 600 mg, 400 mg, and 200 mg without add-back. Elagolix 600 mg without add-back therapy had a significantly higher risk of amenorrhea than lower doses of elagolix with and without add-back and relugolix as well. Uterine volume changes were more pronounced in therapies without add-back. All treatments were associated with significantly improved quality of life scores, both for myoma symptom-related and overall health-related scores. With the exception of relugolix with high-dose add-back, all treatments significantly increased low-density lipoprotein (LDL) levels. Again, all treatment modalities except for elagolix 200 mg without add-back significantly increased LDL-to-HDL ratio. The increase was highest for treatment without add-back therapy.Conclusion: Oral GnRH antagonists seem to be effective for myoma-associated bleeding and for improving quality of life. The safety profile is acceptable for short-term use, but lipid metabolism is affected. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
7. Progestin-primed ovarian stimulation: for whom, when and how?
- Author
-
Ata, Baris and Kalafat, Erkan
- Subjects
- *
INDUCED ovulation , *EMBRYO transfer , *REPRODUCTIVE technology , *ORAL drug administration , *BIRTH rate - Abstract
Progestin-primed ovarian stimulation (PPOS) is being increasingly used for ovarian stimulation in assisted reproductive technology. Different progestins have been used with similar success. The available studies suggest a similar response to ovarian stimulation with gonadotrophin-releasing hormone (GnRH) analogues. Any differences in the duration of stimulation or gonadotrophin consumption are minor and clinically insignificant. PPOS has the advantage of oral administration and lower medication costs than GnRH analogues. As such it is clearly more cost-effective for fertility preservation and planned freeze-all cycles, but when fresh embryo transfer is intended PPOS can be less cost-effective depending on the local direct and indirect costs of the additional initial frozen embryo transfer cycle. Oocytes collected in PPOS cycles have similar developmental potential, including blastocyst euploidy rates. Frozen embryo transfer outcomes of PPOS and GnRH analogue cycles seem to be similar in terms of both ongoing pregnancy/live birth rates and obstetric and perinatal outcomes. While some studies have reported lower cumulative live birth rates with PPOS, they have methodological issues, including arbitrary definitions of the cumulative live birth rate. PPOS has been used in all patient types (except progesterone receptor-positive breast cancer patients) with consistent results and seems a patient friendly and cost-effective choice if a fresh embryo transfer is not intended. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Should the trigger to oocyte retrieval interval be different in progestin-primed ovarian stimulation cycles?
- Author
-
Ata, Baris, Cakar, Aysu, Türkgeldi, Engin, Yildiz, Sule, Keles, İpek, and Kalafat, Erkan
- Subjects
- *
INDUCED ovulation , *OOCYTE retrieval , *MENSTRUAL cycle , *CHORIONIC gonadotropins , *GONADOTROPIN releasing hormone - Abstract
Does the trigger to oocyte retrieval interval (TORI) affect oocyte maturation rates differently in progestin-primed ovarian stimulation (PPOS) and gonadotrophin-releasing hormone (GnRH) antagonist cycles? This was a retrospective cohort study. The interaction between the stimulation protocol and TORI was assessed in a linear mixed effects multivariable regression analysis with oocyte maturation rate as the dependent variable, and stimulation protocol (GnRH antagonist or PPOS), age (continuous), gonadotrophin type (FSH or human menopausal gonadotrophin), trigger (human chorionic gonadotrophin [HCG] or GnRH agonist), TORI (continuous) and days of stimulation (continuous) as the independent variables. Oocyte maturation rate was defined as number of metaphase II oocytes/number of cumulus–oocyte complexes retrieved. The maturation rate was calculated per cycle and treated as a continuous variable. A total of 473 GnRH antagonist and 205 PPOS cycles (121 conventional PPOS and 84 flexible PPOS) were analysed. The median (quartiles) female age was 36 (32–40) years. Of these cycles, 493 were triggered with HCG and 185 with a GnRH agonist. The TORI ranged between 33.6 and 39.1 h, with a median (quartiles) of 36.2 (36–36.4) hours. Maturation rates were similar between fixed PPOS, flexible PPOS and antagonist cycles (median 80%, 75% and 75%, respectively, P = 0.15). There was no significant interaction between the stimulation protocols and TORI for oocyte maturation. PPOS cycles do not seem to require a longer TORI than GnRH antagonist cycles. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Placental deficiency during maternal SARS-CoV-2 infection.
- Author
-
Celik, Ebru, Vatansever, Cansel, Ozcan, Gulin, Kapucuoglu, Nilgun, Alatas, Cengiz, Besli, Yesim, Palaoglu, Erhan, Gursoy, Tugba, Manici, Mete, Turgal, Mert, Dogan, Ozlem, Cekic, Sebile Guler, Duru, Banu, Ata, Baris, Ergonul, Onder, and Can, Fusun
- Abstract
Introduction: Maternal anti-SARS-CoV-2 Spike antibodies can cross the placenta during pregnancy, and neonates born to infected mothers have acquired antibodies at birth. Few studies reported data on the histopathological changes of the placenta during infection and placental infection. SARS-CoV-2 infection may cause impaired development of the placenta, thus predisposing maternal and fetal unfavorable outcomes. The prospective study aims to evaluate the risk of vertical transmission of SARS-CoV-2 and placental passage of anti-Spike antibodies as well as the impact of clinical severity on placental structures.Methods: This is a prospective cohort study on 30 pregnant women infected by SARS-CoV-2 with their neonates. The demographic features and pregnancy outcomes were collected. Gross and microscopic examinations of the placentas were done. Maternal and umbilical cord sera were obtained at the time of delivery. Nasopharyngeal swabs were collected from neonates immediately after birth.Results: The concentrations of total anti-SARS-CoV-2 Spike antibodies were higher in pregnant women with moderate to severe/critical disease. The maternal total anti-SARS-CoV-2 Spike levels were correlated with those of neonatal levels. The rate of placental abnormalities is high in the mothers with severe disease, and those with positive anti-SARS-CoV-2 IgM. All neonates had negative nasopharyngeal swabs for SARS- CoV-2 infections and all placentas were negative in immunohistochemical staining for Spike protein.Discussion: The maternally derived anti-SARS-CoV-2 Spike antibody can transmit to neonates born to infected mothers regardless of gestational age. Our results indicated that the disease severity is associated with ischemic placental pathology which may result in adverse pregnancy outcomes. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
10. A new definition of recurrent implantation failure on the basis of anticipated blastocyst aneuploidy rates across female age.
- Author
-
Ata, Baris, Kalafat, Erkan, and Somigliana, Edgardo
- Subjects
- *
BLASTOCYST , *ANEUPLOIDY , *OLDER patients , *OLDER women , *GENETIC testing , *INFERTILITY treatment , *RESEARCH , *MATHEMATICAL models , *RESEARCH methodology , *FETAL development , *MEDICAL cooperation , *EVALUATION research , *EMBRYO transfer , *INFERTILITY , *TREATMENT failure , *RISK assessment , *COMPARATIVE studies , *MATERNAL age , *THEORY , *FERTILITY , *FERTILIZATION in vitro - Abstract
Objective: To present a definition of recurrent implantation failure that accounts for the effects of female age and anticipated blastocyst euploidy rates on cumulative implantation rates.Design: Mathematical modeling.Setting: Not applicable.Patient(s): Not applicable.Intervention(s): Mathematical modeling of cumulative implantation probability on the basis of published blastocyst euploidy rates across categories of female age.Main Outcome Measure(s): The number of blastocysts required to achieve 95% cumulative implantation probability under the assumption of the absence of any other factor affecting implantation.Result(s): When the euploidy status of the transferred embryo is unknown (i.e., not subjected to preimplantation genetic testing for aneuploidies), our simulation shows that no age category reaches 95% cumulative probability of implantation of at least one embryo until after transfer of seven blastocysts. The number of blastocysts required to reach the same threshold is higher for older patients. For example, women older than 38 years require transfer of more than 10 untested blastocysts for the upper range of predictive probability to meet the threshold of 95%. On the other hand, if the implantation rate for a euploid blastocyst is assumed to be 55%, then 4 blastocysts are enough to reach a cumulative probability rate greater than 95%, regardless of age.Conclusion(s): The term "recurrent implantation failure" should be a functional term guiding further management. We suggest that recurrent implantation failure should not be called until implantation failure becomes reasonably likely to be caused by factors other than embryo aneuploidy, the leading cause of implantation failure. We propose a new definition that factors in anticipated blastocyst euploidy rates across categories of female age, euploid blastocyst implantation rate, and a specified threshold of cumulative probability of implantation. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
11. DOES RECURRENT IMPLANTATION FAILURE EXIST? PREVALENCE AND OUTCOMES OF FIVE CONSECUTIVE EUPLOID BLASTOCYST TRANSFERS IN 123,987 PATIENTS.
- Author
-
Gill, Pavan, Ata, Baris, Arnanz, Ana, Cimadomo, Danilo, Vaiarelli, Alberto, Fatemi, Human M.M., Ubaldi, Filippo Maria, Garcia-Velasco, Juan A., and Seli, Emre
- Subjects
- *
EMBRYO implantation , *BLASTOCYST - Published
- 2023
- Full Text
- View/download PDF
12. Free your patients and yourself from day 2–3: start ovarian stimulation any time in freeze-all cycles.
- Author
-
Ata, Baris, La Marca, Antonio, and Polyzos, Nikolaos P.
- Subjects
- *
INDUCED ovulation , *OVUM donation , *OOCYTE retrieval , *REPRODUCTIVE technology , *MENSTRUAL cycle , *FROZEN human embryos - Abstract
Ovarian stimulation for assisted reproductive technology is traditionally started in the early follicular phase. The essential rationale is to allow timely follicle growth and oocyte retrieval to ensure synchronization of the in-vitro cultured embryos with the receptive period of the endometrium in a fresh transfer cycle. In addition, conventional thought suggested that follicle recruitment happened only once, around menstruation. A deeper understanding of folliculogenesis, advances in cryobiology and an increasing proportion of freeze-all cycles provide a unique opportunity here. Experience from oncofertility patients as well as infertile women and oocyte donors who underwent ovarian stimulation in different phases of the menstrual cycle, dubbed 'random start' cycles, suggests that the number of oocytes collected and their reproductive potential do not depend on the time of starting ovarian stimulation, although the duration of stimulation and gonadotrophin consumption can vary slightly. It may be time to free both patients and clinics from the obsession with starting ovarian stimulation in the early follicular phase in planned freeze-all cycles. The flexibility provided by random start cycles is one aspect of individualizing treatment to patients' needs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Quality or quantity? Pitfalls of assessing the effect of endometrial thickness on live birth rates.
- Author
-
Ata, Baris and Kalafat, Erkan
- Subjects
- *
BIRTH rate - Published
- 2022
- Full Text
- View/download PDF
14. Premature ovulation; is any risk small enough to take when avoidable?
- Author
-
Turkgeldi, Engin and Ata, Baris
- Subjects
- *
OVULATION - Published
- 2021
- Full Text
- View/download PDF
15. Association of 'normal' early follicular FSH concentrations with unexpected poor or suboptimal response when ovarian reserve markers are reassuring: a retrospective cohort study.
- Author
-
Del Gallego, Raquel, Lawrenz, Barbara, Ata, Baris, Kalafat, Erkan, Melado, Laura, Elkhatib, Ibrahim, and Fatemi, Human
- Subjects
- *
OVARIAN reserve , *OVARIAN follicle , *INDUCED ovulation , *ANTI-Mullerian hormone , *MENSTRUAL cycle - Abstract
Are basal FSH measurements, when elevated within its normal range, useful for assessing overall ovarian response and predicting unexpected poor or suboptimal ovarian response? Retrospective cohort study of ovarian stimulation cycles. A total of 1058 ovarian stimulation cycles (891 first, 167 repeated) were included. Anti-Müllerian hormone (AMH) values were categorized into four (0 to ≤0.6, >0.6 to ≤1.2, >1.2 to ≤3.0, >3.0 to ≤6.25 ng/ml) and basal FSH levels into four groups (<25th percentile: >3.5 to 6.1 IU/ml; 25–75th percentile: >6.1 to ≤8.5 IU/ml; >75–90th percentile: >8.5 to ≤9.9 IU/ml; >90th percentile: >9.9 to ≤12.5 IU/ml). Including only first cycles, a significant independent effect of basal FSH on retrieved cumulus–oocyte complex (COC) count was seen for all basal FSH categories (>90th, >75 to ≤90th, >25 to ≤75th compared with ≤25th percentile, P < 0.001, P = 0.001 and P = 0.007, respectively), when adjusted for age, body mass index (BMI), AMH, antral follicle count (AFC), starting dose and gonadotrophin type. Including only first cycles, patients aged 35 years or older with AFC of 5 or above and AMH 1.2 ng/ml or above, showed significantly higher odds of unexpected poor or suboptimal response if they had higher basal FSH values. Most prominently in the above 90th percentile group (OR 8.64, 95% CI 2.84 to 28.47 compared with <25th percentile) but lower categories (>25th to ≤75th percentile: OR 3.04, 95% CI 1.42 t 6.99; >75th to ≤90th percentile: OR 3.47, 95% CI 1.28 to 9.83 compared with ≤25th percentile) also showed a significant association after adjusting for age, AMH, BMI, AFC, dose, and gonadotrophin type. In patients with a second cycle, an increase in FSH levels in the second round compared with the first was associated with fewer retrieved COCs (estimate: –0.44, 95% CI –0.44 to –0.05, P = 0.027). This effect was adjusted for changes in age, FSH, AFC, starting dose, stimulation duration and change in medication type. Basal FSH is independently associated with overall ovarian response. Moreover, it is associated with unexpected poor or suboptimal response in patients, who would fulfill POSEIDON group 2 criteria after oocyte retrieval. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Recurrent implantation failure: reality or a statistical mirage?: Consensus statement from the July 1, 2022 Lugano Workshop on recurrent implantation failure.
- Author
-
Pirtea, Paul, Cedars, Marcelle I., Devine, Kate, Ata, Baris, Franasiak, Jason, Racowsky, Catherine, Toner, Jim, Scott, Richard T., de Ziegler, Dominique, and Barnhart, Kurt T.
- Subjects
- *
EMBRYO implantation , *REPRODUCTIVE technology , *EMBRYO transfer , *OPTICAL illusions , *REPRODUCTIVE health , *INFERTILITY , *MALE infertility - Abstract
To date, recurrent implantation failure (RIF) has no clear definition and no clearly identified impaired function. Hence, the term RIF is currently used somewhat haphazardly, on the basis of clinicians' judgment. International experts in reproductive medicine met on July 1, 2022, in Lugano, Switzerland, to review the different facets of RIF and define the diagnosis and its appropriate management. A systematic review without meta-analysis of studies published in English from January 2015 to May 2022. Data indicated that RIF has been largely overevaluated, overdiagnosed, and overtreated without sufficient critical assessment of its true nature. Our analyses show that true RIF is extremely uncommon—occurring in <5% of couples with infertility—and that reassurance and continued conventional therapies are warranted in most cases of assisted reproductive technology (ART) failure. Although the true biologic determinants of RIF may exist in a small subset of people with infertility, they elude the currently available tools for assessment. Without identification of the true underlying etiology(ies), it is reasonable not to assign this diagnosis to a patient until she has failed at least 3 euploid blastocyst transfers (or the equivalent number of unscreened embryo transfers, adjusted to the patient's age and corresponding euploidy rate). In addition, other factors should be ruled out that may contribute to her reduced odds of sustained implantation. In such cases, implantation failure should not be the only issue considered in case of ART failure because this may result from multiple other factors that are not necessarily repetitive or persistent. In reality, RIF impacting the probability of further ART success is a very rare occurrence. True RIF is extremely uncommon, occurring in <5% of couples with infertility. Reassurance and continued conventional therapies are warranted in most cases. It would seem reasonable not to assign this diagnosis to a patient until she has failed at least 3 euploid embryo transfers (or the equivalent number of unscreened embryos, adjusted to her age). Given the number of internationally recognized experts in the field present at the Lugano meeting 2022, our publication constitutes a consensus statement. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Recurrent implantation failure: a plea for a widely adopted rational definition.
- Author
-
Somigliana, Edgardo, Busnelli, Andrea, Kalafat, Erkan, Viganò, Paola, and Ata, Baris
- Subjects
- *
EMBRYO implantation , *OOCYTE retrieval , *EMBRYO transfer , *DEFINITIONS , *SCIENTIFIC community - Abstract
Most proposed definitions of recurrent implantation failure (RIF) are based on clinical judgement, probably affected by patients' demands. They are not based on robust statistical considerations. As a result, a diagnosis of RIF is commonly made too early, exposing couples to the risk of overdiagnosis and overtreatment. However, the situation is changing, and three statistical approaches have recently been proposed. The first is a probability model based on the chances of success per cycle and suggests for the definition three failed oocyte retrieval cycles with all embryos being transferred in women younger than 40 years of age. The second approach suggests an individualized diagnosis that takes into consideration multiple factors, while the third is also based on individualization but mainly relies on anticipated euploidy rates across the female age range. All these approaches have their pros and cons. Regardless of the specific peculiarities, they represent steps in the right direction, with the intent of providing a statistically sound definition. However, these attempts will not be useful unless endorsed by the scientific community in general. There is a pressing need for a rigorous and shared definition of RIF that will be widely accepted by researchers, scientific societies and other stakeholders, including patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Endometrial thickness is not predictive for live birth after embryo transfer, even without a cutoff.
- Author
-
Shakerian, Bahar, Turkgeldi, Engin, Yildiz, Sule, Keles, Ipek, and Ata, Baris
- Subjects
- *
EMBRYO transfer , *REPRODUCTIVE technology , *BIRTH rate , *UNIVERSITY hospitals , *PROGESTERONE , *INFERTILITY treatment , *ULTRASONIC imaging , *PREDICTIVE tests , *MISCARRIAGE , *RETROSPECTIVE studies , *FETAL development , *INFERTILITY , *PREGNANCY outcomes , *RISK assessment , *TREATMENT effectiveness , *FERTILITY , *FERTILIZATION in vitro , *ENDOMETRIUM - Abstract
Objective: To investigate the predictive value of endometrial thickness (EMT) for live birth when a lower threshold of EMT is not employed for embryo transfer (ET).Design: Retrospective study SETTING: Academic assisted reproduction center PATIENT(S): All women who underwent fresh or frozen-thawed ET at the Koç University Hospital Assisted Reproduction Unit between October 2016 and August 2019 INTERVENTION(S): After ruling out endometrial pathology, blastocyst transfer was planned regardless of the EMT in the absence of increased serum progesterone level on the trigger day in fresh embryo transfer cycles or before commencing progesterone treatment in artificially prepared frozen-thawed ET cycles.Main Outcome Measure(s): The primary outcome was live birth. Live birth and miscarriage rates per ET were stratified according to fresh and frozen-thawed ET cycles for each millimeter of endometrial thickness. Receiver operator characteristic curve analyses were performed to evaluate the predictive value of EMT for live birth.Result(s): A total of 560 ET cycles, 273 fresh and 287 frozen-thawed, were included in the study. Relevant patient characteristics as well as EMTs were similar between women who achieved a live birth and those who did not after fresh or frozen-thawed ET. There was no linear association between EMT and live birth or miscarriage rates. Area under the curve values for EMT to predict live birth after fresh, frozen-thawed, and all ETs were 0.56, 0.47, and 0.52, respectively.Conclusion(s): Our results showed that the EMT was not predictive for live birth in either fresh or frozen-thawed ET cycles. Once intracavitary pathology and inadvertent progesterone exposure were excluded, women with thinner EMTs should not be denied their potential for live birth because it is comparable to that of those with thicker EMT. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
19. Time-lapse morphokinetic parameters and implantation outcomes of single euploid embryo transfers.
- Author
-
Benlioglu, Can, Keles, Ipek, Kalafat, Erkan, Ata, Baris, and Bozdag, Gurkan
- Subjects
- *
EMBRYO implantation , *EMBRYO transfer , *INTRACYTOPLASMIC sperm injection , *LIKELIHOOD ratio tests , *MATERNAL age , *FERTILIZATION in vitro , *TREATMENT delay (Medicine) - Abstract
The study explores the factors influencing the implantation success rate of euploid embryos. We primarily aim to understand the relationship between morphokinetics and implantation outcomes, considering potential confounding variables such as maternal age and morphological features of the embryos. Additionally, we intend to elucidate the role of morphological grading in the interplay between morphokinetics and implantation rates in euploid single embryo transfers. The present retrospective study was conducted between January-2016 and January-2023 in a tertiary university hospital's IVF clinic. Forty-four patients who were followed up in time-lapse incubation (Embryoscope, VitroLife) after intracytoplasmic sperm injection (ICSI) procedure were included. All embryos were individually cultured in a time-lapse incubator from ICSI up to the stage of trophectoderm biopsy. Images were recorded with the use of the integrated microscope in every 15 minutes from seven different focal planes. All annotations were made in a prospective fashion by single experienced senior embryologist. A longitudinal dataset containing information on individuals over time was used with a multilevel modeling approach. A linear mixed-effects model was used to analyze the data. The outcome variable (implantation) was modeled as a function of the time intervals, with random effects for the individual. The significance of the fixed effects was tested using a likelihood ratio test. A p-value of less than 0.05 was considered statistically significant. In 44 transferred single euploid embryos, 30 were implanted (68.1%). There was no marked disparity in demographic distributions between the failure or successful implantation groups (for female age, median (IQR) 39.0 (35.5 to 40.0) vs. 39.0 (34.0 to 40.0), p =.751; for male age, median (IQR) 41.5 (38.2 to 43.8) vs. 39.5 (36.0 to 42.8), p=.318; for BMI median (IQR) 23.3 (21.5 to 25.9) vs. 24.7 (23.3 to 28.2), p=.212). Regarding morphological factors, a significant correlation between inner cell mass (ICM) grade and implantation rate was found (p=.001), but it was not observed in trophectoderm grades (p=.103). In the LME (both fixed and random effects were used) model (fixed effects coefficients were the morphokinetic parameters, random effects were the individual embryos, and the outcome was implantation), a significant negative trend was demonstrated between the delay in the last quartile of embryo timeline and implantation. Specifically, a 50% decline in implantation rates was observed in the last quartile with a 9-hour delay (p=.0369, standard error=.3692). However, adding ICM grades to the LME model diminishes the negative trend (p=.99575). The study indicates that morphokinetics may play a role in the success of euploid single embryo transfer procedures, especially within specific temporal windows might impact implantation rates in euploid SET. However, association is diminished when considered with morphological grading of the embryo. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. SEVEN-YEAR FOLLOW-UP OF PLANNED OOCYTE CRYOPRESERVATION OF WOMEN WITH DIMINISHED OVARIAN RESERVE AND/OR ADVANCED AGE: RETURN RATES AND CYCLE OUTCOMES.
- Author
-
Cil, Aylin P., Telce Gurbuz Kucukceran, Telce Aysen, Abali, Remzi, Keles, Ipek, Karakis, Lale S., Aksakal, Ece, Ceyhan, Mehmet, Ata, Baris, Oktem, Ozgur, Balaban, Basak, Findikli, Necati, Bahceci, Mustafa, and Urman, Bulent
- Subjects
- *
OVARIAN reserve , *OVUM , *AGE - Published
- 2023
- Full Text
- View/download PDF
21. A critical appraisal of studies on endometrial thickness and embryo transfer outcome.
- Author
-
Mathyk, Begum, Schwartz, Adina, DeCherney, Alan, and Ata, Baris
- Subjects
- *
EMBRYO transfer , *SEXUAL cycle , *REPRODUCTIVE technology , *EMBRYO implantation , *ENDOMETRIUM - Abstract
A receptive endometrium is required for successful embryo implantation. Endometrial thickness, as measured by ultrasonography, is the most commonly used marker of endometrial receptivity in assisted reproductive technology cycles. Several factors simultaneously affect both endometrial thickness and probability of live birth, including age, oestradiol concentration and oocyte number, among others. Most of the studies investigating a relationship between endometrial thickness and embryo transfer outcomes are retrospective and do not adequately address confounding factors, in addition to other limitations. Despite multiple meta-analyses and studies with large numbers of cycles, controversy still exists. The difference between the results from prospective and retrospective studies is also striking. This article presents a critical appraisal of the studies on endometrial thickness and embryo transfer outcomes in order to highlight methodological issues and how they can be overcome in future studies. Currently available evidence does not seem to support a modification of management just because endometrial thickness is below an arbitrary threshold. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
22. Reply of the Authors: Recurrent implantation failure: reality or a statistical mirage?
- Author
-
Pirtea, Paul, Cedars, Marcelle I., Devine, Kate, Ata, Baris, Franasiak, Jason, Racowsky, Catherine, Toner, Jim, Scott, Richard T., de Ziegler, Dominique, and Barnhart, Kurt T.
- Subjects
- *
EMBRYO implantation , *OPTICAL illusions , *AUTHORS - Published
- 2023
- Full Text
- View/download PDF
23. EFFECT OF HEMOSTATIC METHODS USED IN LAPAROSCOPIC SURGERY FOR OVARIAN ENDOMETRIOMA ON OVARIAN RESERVE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED TRIALS.
- Author
-
Kalafat, Erkan, Aslan, Batuhan, Berkkan, Metehan, Sonmezer, Murat, Atabekoglu, Cem Somer, and Ata, Baris
- Subjects
- *
OVARIAN reserve , *LAPAROSCOPIC surgery , *ENDOMETRIOSIS - Published
- 2022
- Full Text
- View/download PDF
24. CLINICAL FACTORS ASSOCIATED WITH SUBOPTIMAL BLASTULATION RATE IN ICSI CYCLES: A PARAMETRIC MODELING APPROACH.
- Author
-
Kalafat, Erkan, Keles, Ipek, Turkgeldi, Engin, Yildiz, Sule, Bozdag, Gurkan, and Ata, Baris
- Subjects
- *
PARAMETRIC modeling - Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.